BeStock  

Aquestive Therapeutics AQST

US equityMarket cap rank #3651Drug Manufacturers - Specialty & Generic
$3.46 −$0.25 (-6.61%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.52 +1.73%
Open$3.62
Prev close$3.71
Day range$3.41 – $3.65
Volume3.36M
Market cap$434.88M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$9.25+167.3% vs. price
  • Buy 100%
Low $6.00Now $3.46Avg $9.25High $11.00

Recent rating changes

The last 20 actions on file set price targets from $6.00 to $11.00, averaging $9.00.

DateFirmRatingTarget
9 Nov 2026 H.C. Wainwright BUY $10.00
5 Nov 2026 Leerink Partners BUY $11.00
16 Oct 2026 H.C. Wainwright BUY $10.00
15 Oct 2026 H.C. Wainwright BUY $10.00
21 Sep 2026 H.C. Wainwright BUY $10.00
17 Sep 2026 LifeSci Capital BUY $10.00
17 Sep 2026 Lake Street BUY $6.00
24 Aug 2026 H.C. Wainwright BUY $10.00
13 Aug 2026 LifeSci Capital BUY $10.00
10 Aug 2026 LifeSci Capital BUY $10.00
10 Aug 2026 Lake Street BUY $6.00
25 Jun 2026 Cantor Fitzgerald BUY $11.00
25 Jun 2026 Chardan Capital BUY $8.00
25 Jun 2026 LifeSci Capital BUY $9.00
15 May 2026 LifeSci Capital BUY $9.00
15 May 2026 Piper Sandler BUY $8.00
15 May 2026 Leerink Partners BUY $9.00
15 May 2026 Lake Street BUY $6.00
15 May 2026 Oppenheimer BUY $8.00
14 May 2026 A. G. P. BUY $9.00

Discussion

No comments yet — be the first to weigh in on AQST.

Sign in to join the discussion.

Scroll to Top